 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| F527 / Lunan Pharma
New P1 trial: Study of F527 in Patients With Relapsed or Refractory Lymphoma (clinicaltrials.gov) - Mar 22, 2022
P1, N=82, Not yet recruiting, Sponsor: Shandong New Time Pharmaceutical Co., LTD